Background: Tenecteplase is used as an alternative to alteplase and is considered noninferior for thrombolysis in acute ischemic stroke. Objectives: To compare the effectiveness and adverse effects of tenecteplase and alteplase in the real-world ...
Arpan Dutta +14 more
doaj +1 more source
La ténectéplase pour la thrombolyse d’un AVC ischémique aigu chez une femme de 68 ans. [PDF]
Khan F +4 more
europepmc +1 more source
Advances in Reperfusion Therapy and Cytoprotection for Acute Ischemic Stroke. [PDF]
Li Z, Wang C.
europepmc +1 more source
Thrombolysis for pulmonary embolism: A network meta-analysis. [PDF]
Ross A +3 more
europepmc +1 more source
''Sugar for the Heart'', a bitter pill for tenecteplase: the crystallisation trap of pre-hospital fibrinolysis. [PDF]
Prevautel T, Adet A, Michoud G.
europepmc +1 more source
Tenecteplase in the Extended 4.5-24-Hour Window for Acute Ischemic Stroke: An Updated Meta-Analysis of RCTs with EVT-Stratified Subgroup Analysis. [PDF]
Qazi S +11 more
europepmc +1 more source
Comparison of the efficacy and safety of different thrombolytic drugs in the treatment of acute ischemic stroke within 4.5 h: a systematic review and network meta-analysis. [PDF]
Yu X +6 more
europepmc +1 more source
Dose-Specific Intra-Arterial Thrombolysis After Endovascular Thrombectomy for Large-Vessel Occlusion Stroke: A Network Meta-Analysis of Randomized Trials. [PDF]
Frechiani LEC, Louzada HL.
europepmc +1 more source
Efficacy and safety of tenecteplase versus urokinase in the treatment of acute ischemic stroke. [PDF]
Li D, Huang S, Wang X, Hong Z, Qiu X.
europepmc +1 more source

